These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
154 related articles for article (PubMed ID: 6340451)
1. Mexiletine for control of drug-resistant ventricular tachycardia: clinical and electrophysiologic results in 44 patients. Waspe LE; Waxman HL; Buxton AE; Josephson ME Am J Cardiol; 1983 Apr; 51(7):1175-81. PubMed ID: 6340451 [TBL] [Abstract][Full Text] [Related]
2. Electrophysiologic effects and clinical efficacy of mexiletine used alone or in combination with class IA agents for refractory recurrent ventricular tachycardias or ventricular fibrillation. Kim SG; Felder SD; Waspe LE; Fisher JD Am J Cardiol; 1986 Sep; 58(6):485-90. PubMed ID: 3529910 [TBL] [Abstract][Full Text] [Related]
3. Efficacy of combination therapy with mexiletine and a type IA agent for inducible ventricular tachyarrhythmias secondary to coronary artery disease. Greenspan AM; Spielman SR; Webb CR; Sokoloff NM; Rae AP; Horowitz LN Am J Cardiol; 1985 Aug; 56(4):277-84. PubMed ID: 4025166 [TBL] [Abstract][Full Text] [Related]
4. Mexiletine for refractory-ventricular arrhythmias: results using serial electrophysiologic testing. DiMarco JP; Garan H; Ruskin JN Am J Cardiol; 1981 Jan; 47(1):131-8. PubMed ID: 7457398 [TBL] [Abstract][Full Text] [Related]
5. Oral mexiletine in the treatment of refractory ventricular arrhythmias: the role of electrophysiologic techniques. Schoenfeld MH; Whitford E; McGovern B; Garan H; Ruskin JN Am Heart J; 1984 May; 107(5 Pt 2):1071-8. PubMed ID: 6372423 [TBL] [Abstract][Full Text] [Related]
6. Mexiletine for recurring ventricular arrhythmias: assessment by long-term electrocardiographic recordings and sequential electrophysiologic studies. Flaker GC; Madigan NP; Alpert MA; Moser SA Am Heart J; 1984 Sep; 108(3 Pt 1):490-5. PubMed ID: 6475711 [TBL] [Abstract][Full Text] [Related]
7. Intolerance and ineffectiveness of mexiletine in patients with serious ventricular arrhythmias. Poole JE; Werner JA; Bardy GH; Graham EL; Pulaski WP; Fahrenbruch CE; Greene HL Am Heart J; 1986 Aug; 112(2):322-6. PubMed ID: 3739884 [TBL] [Abstract][Full Text] [Related]
8. Role of combination drug therapy with a class IC antiarrhythmic agent and mexiletine for ventricular tachycardia. Mendes L; Podrid PJ; Fuchs T; Franklin S J Am Coll Cardiol; 1991 May; 17(6):1396-402. PubMed ID: 2016457 [TBL] [Abstract][Full Text] [Related]
9. Comparison of the antiarrhythmic efficacy of disopyramide and mexiletine against stimulus-induced ventricular tachycardia. Breithardt G; Seipel L; Abendroth RR J Cardiovasc Pharmacol; 1981; 3(5):1026-37. PubMed ID: 6168848 [TBL] [Abstract][Full Text] [Related]
10. Long-term efficacy of mexiletine alone and in combination with class Ia antiarrhythmic drugs for refractory ventricular arrhythmias. Whitford EG; McGovern B; Schoenfeld MH; Garan H; Newell JB; McElroy M; Ruskin JN Am Heart J; 1988 Feb; 115(2):360-6. PubMed ID: 3341170 [TBL] [Abstract][Full Text] [Related]
11. Quinidine for ventricular arrhythmias: value of electrophysiologic testing. DiMarco JP; Garan H; Ruskin JN Am J Cardiol; 1983 Jan; 51(1):90-5. PubMed ID: 6849270 [TBL] [Abstract][Full Text] [Related]
12. Discordance between ambulatory monitoring and programmed stimulation in assessing efficacy of mexiletine in patients with ventricular tachycardia. Kim SG; Seiden SW; Matos JA; Waspe LE; Fisher JD Am Heart J; 1986 Jul; 112(1):14-9. PubMed ID: 3728269 [TBL] [Abstract][Full Text] [Related]
13. Efficacy of class Ib (lidocaine-like) antiarrhythmic agents for prevention of sustained ventricular tachycardia secondary to coronary artery disease. Reiter MJ; Easley AR; Mann DE Am J Cardiol; 1987 Jun; 59(15):1319-24. PubMed ID: 3109228 [TBL] [Abstract][Full Text] [Related]
14. Electrophysiologic assessment of antiarrhythmic drug efficacy for ventricular tachyarrhythmias associated with dilated cardiomyopathy. Rae AP; Spielman SR; Kutalek SP; Kay HR; Horowitz LN Am J Cardiol; 1987 Feb; 59(4):291-5. PubMed ID: 3544793 [TBL] [Abstract][Full Text] [Related]